Chih‐Wei Yu

Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil

Chao‐Yu Hsu, Ying‐Chun Shen, Chih‐Wei Yu et al. · Journal of Hepatology · 2011 · 117 citations

Hepatology, Hepatocellular Carcinoma Patients, Oncologic Imaging +9

Vertebral osteonecrosis: MR imaging findings and related changes on adjacent levels.

Chih‐Wei Yu, Chao‐Yu Hsu, Tiffany Ting‐Fang Shih et al. · PubMed · 2007 · 111 citations · Full text

Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients

Bang‐Bin Chen, Chao‐Yu Hsu, Chih‐Wei Yu et al. · European Radiology · 2011 · 103 citations

Liver Fibrosis, Hepatology, Medical Imaging +14

Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study

Chiun Hsu, Tsai‐Sheng Yang, Teh‐Ia Huo et al. · Journal of Hepatology · 2012 · 96 citations

Surgical Oncology, Hepatology, Phase Ii +11

Rhabdomyolysis

Chia-Hung Lu, Yuk‐Ming Tsang, Chih‐Wei Yu et al. · Journal of Computer Assisted Tomography · 2007 · 85 citations